CIK 0001022899 · Non-accelerated filer<br>Smaller reporting company
Protagenic Therapeutics, Inc.new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061390025
- Phone
- (212) 994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- DEF 14A Proxy Proxy Statement
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 10-K/A Report 10-K/A
- 10-K Report Annual Report
- 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Shareholder vote results · Other events
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- 10-K Report Annual Report
- NT 10-K Other NT 10-K
- S-8 Other Securities Offered to Employees in Benefit Plans
- SC 13G Stake Amended Statement of Ownership
Page 6 of 36 · 707 filings